India is home to roughly 7-8% of all recorded species on Earth, despite occupying just 2% of the world’s land area. This extraordinary biological wealth – spanning the Western Ghats, Eastern Himalayas, the Indo-Burma region, and Sundaland – also makes it a prime target for exploitation. When foreign entities began patenting traditional Indian knowledge about turmeric and neem in the 1990s, it became clear that goodwill alone could not protect this heritage. India needed law. The result was the Biological Diversity Act, 2002 (BDA) – a statute designed to translate India’s global commitments under the Convention on Biological Diversity (CBD) into enforceable domestic rights.

Table of Contents

The CBD: the global framework behind the Act

The Convention on Biological Diversity was adopted on 22 May 1992 in Nairobi and opened for signature at the Earth Summit in Rio de Janeiro on 5 June 1992. India signed the CBD on that date and ratified it on 18 February 1994. The Convention rests on three interconnected pillars: the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising out of the utilisation of genetic resources. It also reaffirms the sovereign rights of states over their biological resources – a principle that directly shaped the architecture of India’s domestic legislation.

The CBD additionally requires member nations to protect and conserve traditional knowledge (TK) held by local communities. This obligation is reflected in Article 8(j) of the Convention, which advocates for respecting, protecting, and rewarding the TK of indigenous and local communities. Every major provision of the BDA traces its lineage to one of these CBD mandates.

Why the Biological Diversity Act, 2002 was enacted

India’s Parliament drew its legislative authority from two constitutional provisions: Article 253, which empowers Parliament to legislate for the purpose of giving effect to international agreements, and Article 51, which directs the state to foster respect for international law and treaty obligations. The BDA was formally enacted as Act No. 18 of 2003 and came into force thereafter, with the Biological Diversity Rules following in 2004.

The immediate trigger was the rising incidence of biopiracy – the unauthorised commercial exploitation of India’s biological resources and associated traditional knowledge through patent applications filed abroad. The turmeric and neem cases made this threat viscerally real, and the BDA was designed to close the legal gaps that had allowed such exploitation to occur.

Core objectives of the Act and their alignment with CBD goals

The BDA’s stated objectives directly mirror the CBD’s three pillars:

  • Conservation of biological diversity – protecting ecosystems, species, and genetic material from overexploitation and degradation.
  • Sustainable use of biological resources – ensuring that utilisation does not lead to long-term decline, thereby meeting the needs of present and future generations.
  • Fair and equitable sharing of benefits – ensuring that communities who have conserved and developed knowledge about biological resources receive a share of the commercial gains from their use.

The Act’s definition of “biological diversity” under Section 2(b) – variability among living organisms from all sources, including diversity within and between species and of ecosystems – is drawn almost verbatim from the CBD’s own definition, establishing definitional alignment at the outset.

Regulating access to biological resources: Sections 3 and 6

One of the BDA’s most significant contributions is creating a differentiated, tiered access regime. Section 3 prohibits any foreign individual, company, or organisation from obtaining biological resources occurring in India or knowledge associated with them – for research, commercial utilisation, or bio-survey – without the prior approval of the National Biodiversity Authority (NBA). Indian citizens and body corporates must seek approval from the concerned State Biodiversity Board (SBB) for commercial purposes.

Section 6 adds a critical intellectual property dimension: no person can apply for any IPR – including patents – in or outside India for an invention based on biological resources obtained from India without first obtaining NBA approval. This provision directly targets biopiracy through patent applications and creates a mandatory checkpoint before any IP claim can be filed. The results of any research using Indian biological resources also cannot be transferred to foreign entities without NBA approval.

There are, however, specific exemptions built into the Act. Traditional users – local communities, farmers, livestock keepers, vaids, hakims, and registered AYUSH practitioners – are exempt from the access restrictions when using resources for sustenance and traditional practice. Collaborative research between Indian and foreign institutions approved by the Central Government is similarly permitted under specified conditions.

The three-tier institutional structure

To implement its provisions, the BDA establishes a three-tier institutional framework – one of the most decentralised governance models in Indian environmental law:

  • National Biodiversity Authority (NBA) – a statutory, autonomous body established in 2003 under the Ministry of Environment, Forest and Climate Change, headquartered in Chennai. The NBA regulates foreign access, approves IPR applications involving biological resources, determines benefit-sharing terms, and advises the Central Government on biodiversity policy.
  • State Biodiversity Boards (SBBs) – established by State Governments under Section 22, these bodies deal with access by Indian citizens for commercial purposes, advise state governments on equitable benefit distribution, and regulate bio-survey and bio-utilisation at the state level. No SBB is constituted for Union Territories; the NBA exercises SBB functions there.
  • Biodiversity Management Committees (BMCs) – constituted by every local body under Section 41, BMCs operate at the grassroots level. They document local biological resources and associated knowledge in People’s Biodiversity Registers (PBRs), promote conservation, and participate in benefit-sharing consultations when resources from their area are accessed.

This structure ensures that the CBD’s principle of community-level participation is not just aspirational – it is embedded in the Act’s enforcement architecture.

Access and benefit sharing: Section 21

The Access and Benefit Sharing (ABS) mechanism under Section 21 is the operational heart of the BDA’s alignment with CBD obligations. The NBA determines the terms and mode of benefit sharing, which may take various forms, including monetary compensation, joint ownership of intellectual property rights, technology transfer, capacity-building support, and infrastructural assistance to local communities. The section mandates consultation with BMCs and documentation of traditional knowledge in PBRs before any benefit-sharing arrangement is finalised.

A National Biodiversity Fund is constituted under the Act. Benefit-sharing amounts are deposited into this fund and disbursed directly to individuals, groups, or organisations entitled to them under the terms of any agreement. This creates an accountable financial channel for ensuring that economic gains from biodiversity reach the communities that have historically stewarded it.

India further solidified its ABS commitments by ratifying the Nagoya Protocol on Access and Benefit-Sharing in 2012. The Nagoya Protocol, adopted under the CBD at Nagoya, Japan in 2010, elaborated the ABS framework established by the CBD. India incorporated its principles into domestic law through the BDA and subsequent rules, with the ABS Guidelines of 2014 providing detailed implementation procedures.

Protecting traditional knowledge and combating biopiracy

The BDA’s TK protections are best understood against the backdrop of India’s bitter experience with biopiracy. In 1995, the US Patent and Trademark Office granted a patent to researchers at the University of Mississippi Medical Centre for the use of turmeric in wound healing – a practice common in Indian households for centuries. The Council of Scientific and Industrial Research (CSIR) challenged the patent by presenting ancient Sanskrit texts and contemporary medical literature; the patent was revoked in 1997. Around the same time, a European Patent Office grant for neem-based fungicidal treatment was also challenged using documented evidence of traditional Indian use, and was eventually revoked in 2000 after prolonged litigation.

These cases directly shaped the BDA’s design. The Act’s Section 6 requirement for NBA approval before filing patent applications, combined with India’s Traditional Knowledge Digital Library (TKDL) – a searchable database of traditional Indian medicinal knowledge made accessible to patent offices globally – creates a two-pronged defence against future biopiracy. The TKDL now gives patent examiners in jurisdictions including the US, Europe, and Australia a structured basis for identifying prior art rooted in Indian traditional practice.

The NBA has also invoked the BDA in active enforcement. When MAHYCO (in partnership with Monsanto) accessed at least 10 indigenous varieties of brinjal from Karnataka and Tamil Nadu to develop Bt brinjal without obtaining prior consent from the NBA, SBBs, or local BMCs, the NBA initiated legal proceedings against the companies for violating the Biological Diversity Act, 2002. This was among the first major enforcement actions taken under the Act and demonstrated that its provisions were not merely declaratory.

Conservation and sustainable use provisions

Beyond regulating access, the BDA contains several provisions aimed at the first two CBD pillars – conservation and sustainable use. The Central Government, in consultation with the NBA, is empowered to notify threatened species and regulate or prohibit their collection, rehabilitation, and conservation. The Act also allows designation of Biodiversity Heritage Sites – areas of significant biodiversity importance – by the Central Government through notification in the Official Gazette.

The Act’s definition of sustainable use is explicit: utilisation of biological resources at a rate that does not lead to their long-term decline, thereby maintaining the potential of biodiversity to meet the needs of both present and future generations. This framing is directly derived from CBD language and reinforces that the BDA is not merely a regulatory checkpoint but a framework for long-term stewardship.

Penalties and enforcement

The BDA gives its provisions teeth through a stringent penalty regime. Violations of the Act are cognizable and non-bailable offences under Section 58, punishable with imprisonment for a term that may extend to five years, or a fine that may extend to ten lakh rupees. Where damage caused exceeds ten lakh rupees, the fine is calibrated proportionately. Grievances relating to benefit-sharing determinations or orders of the NBA or SBBs are adjudicated by the National Green Tribunal (NGT), ensuring an independent and specialised forum for dispute resolution.

Challenges and the road ahead

Despite its comprehensive architecture, the BDA faces practical limitations. Critics point out that the Act places excessive focus on preventing profit-sharing from commercial use, at times at the expense of broader conservation goals. Many local communities remain unaware of their rights under the Act, and benefit-sharing agreements have often been delayed or inadequately implemented at the grassroots level. Coordination gaps between the NBA, SBBs, and BMCs also slow down governance. Additionally, the rise of digital sequence information (DSI) – genetic data extracted from biological resources and stored in digital databases – poses new regulatory challenges that the original statute did not anticipate.

Ongoing reform efforts include digitising People’s Biodiversity Registers for transparency, integrating the TKDL more deeply into patent examination workflows, and aligning India’s domestic framework with evolving international obligations, including recent WIPO negotiations on IP protection for genetic resources and traditional knowledge. The Biological Diversity (Amendment) Act, 2023 represents the most recent legislative effort to refine these mechanisms, with an emphasis on easing compliance for certain categories of users while strengthening protections for communities.

India’s Biological Diversity Act, 2002 stands as one of the most detailed domestic implementations of CBD principles globally. It translates the Convention’s aspirations – sovereign rights over biological resources, equitable benefit sharing, and community participation – into concrete regulatory obligations backed by institutional machinery and penal consequences. Its effectiveness ultimately depends on consistent enforcement, genuine community participation, and the ability to adapt to emerging threats like digital biopiracy.

What do you think? Does the current three-tier structure of the NBA, SBBs, and BMCs give enough real power to local communities to protect their biological resources – or does the framework still concentrate decision-making too heavily at the national level? And with genetic sequence data increasingly replacing the need to physically access biological samples, should India amend the BDA to explicitly regulate digital access to biodiversity information?

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

References
  1. https://vajiramandravi.com/current-affairs/biodiversity-act-2002/
  2. https://abs.nls.ac.in/?page_id=219
  3. https://www.indiacode.nic.in/bitstream/123456789/21545/1/the_biological_diversity_act,_2002.pdf
  4. https://www.legalbites.in/environment-law/the-biological-diversity-act-2002-overview-of-access-and-benefit-sharing-provisions-1128830
  5. https://legal60.com/the-biological-diversity-act-2002-overview-of-access-and-benefit-sharing-provisions/
  6. https://www.lexology.com/library/detail.aspx?g=1c132aa5-97af-4164-af22-ca3c240ab172
  7. https://www.iam-media.com/article/biopiracy-in-india-scientific-eruption-or-traditional-disruption

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Patents

1 Fundamentals of Patenting

  1. Historical Background of Patents
  2. Types of Patents
  3. World Patent
  4. Procedure for Filing a Patent in India
  5. Filing Patent Application in Other Countries

2 Terms and Definitions

  1. Inventions
  2. Inventive Steps
  3. Capable of Industrial Application
  4. New Invention
  5. Pharmaceutical Substance

3 Rights in Patents

  1. Scope of Patent Protection
  2. Limitation on Patent Rights
  3. Acts Not Considered as Infringement
  4. Compulsory License
  5. Revocation of Patent

4 Administration of Patents

  1. Patent Office
  2. Powers of the Controller General
  3. Register of Patent
  4. Patent Agents
  5. Training of Patent Agents and Examiners
  6. Modernization of Patent Offices
  7. Introducing Patent Education in Science Colleges

5 Procedure for Obtaining A Patent in India

  1. Stages Involved in Grant of a Patent
  2. Type of Patent Applications
  3. Format for Making Application
  4. Appropriate Office
  5. Prescribed Fee
  6. Person Entitled to File
  7. Procedure of Filing Application
  8. Patent of Addition

6 International Patent Search, Documentation and Analytics

  1. Structure of Patent Document
  2. Bibliographic Information Contained in Patent Documents INID Codes
  3. Kind Codes for Patent Documents
  4. International Patent Classification
  5. Types of Searches
  6. Sources of Patent Information
  7. How to Conduct Patent Search
  8. Understanding an International Search Report

7 Patent Specification and Claims

  1. Provisional and Complete Specification
  2. Categories of Invention
  3. Process of Drafting a Patent Specification
  4. Description Requirements of a Patent Specification in Different Jurisdictions
  5. Examples illustrating Various Components of a Patent Specification
  6. Essential Features of Description of an Invention
  7. Filing of a Patent Application at Patent Office

8 Commercialisation of Patents

  1. Objectives of Commercialisation of Patents Organisations
  2. Patent Commercialisation vs Product Marketing
  3. PatentlTechnology Valuations and Pricing
  4. Identifying Potential Licensees
  5. Formulating a Patent Licensing Strategy
  6. Licensing of Patented Know How to Clients in Developed Countries

9 Infringement of Patent

  1. Infringement: Its Meaning
  2. Exceptions to Infringement
  3. Types of Infringement
  4. Determination of Infringement
  5. Jurisdiction of Suit for Infringement
  6. Time for Filing the Suit

10 Filing Opposition- Pre/Post Grant Issues

  1. Pre-Grant Opposition
  2. Post-Grant Opposition
  3. Grounds of Opposition
  4. Procedure for Pre-Grant Opposition
  5. Procedure for Post-Grant Opposition

11 Grounds of Defence

  1. Defences
  2. Revocation Grounds
  3. Gillette Defence
  4. Relief or Remedy
  5. Declaration as to Non-Infringement

12 Intellectual Property Appellate Board (IPAB)

  1. Introduction
  2. Amendments in the Patents Act
  3. Objective of IPAB
  4. Location of IPAB and its Benches
  5. Salient features of the IPAB
  6. Qualifications of the Chairman and Vice-Chairman
  7. Qualifications of the Technical Member Patents
  8. Transfer of Cases
  9. Operationalisation of IPAB for Patents

13 Patent Co-operation Treaty and International Patent Filing Strategies

  1. Introduction
  2. Need for Protecting Inventions Abroad
  3. Using PCT Route for Filing Patent Applications
  4. General Procedure of PCT Filing
  5. Strategies followed by Applicants for PCT Filings
  6. Benefits of Using PCT System

14 Technology Transfer

  1. Introduction
  2. Technology Transfer Activities
  3. Dynamic Relationship between IPR Activity, Technology Transfer, and Commercialisation
  4. Partnerships in Technology Transfer and Development
  5. Methods of Technology Transfer
  6. Major Technology Transfer Organisations in India and Abroad
  7. Government Control on Technology Transfer
  8. Reasons for Failure of a Technology
  9. Future Scenario of Technology Transfer
  10. Practical Examples of Technology Transfer

15 Patents and Indian Biodiversity Act

  1. Convention on Biological Diversity 1992 (CBD)
  2. CBD and Biodiversity Act of India 2002
  3. Provisions in BDA
  4. Sourcing Biological Material and Associated Knowledge from India
  5. Patents Act and Protection of Bio-Resources
  6. Application Format for Access to Biological Resources and Associated Traditional Knowledge
  7. Benefit Sharing and Other Provisions